AshokChauhanMD
Pulmonology • Arlington, VACritical Care Medicine, Interventional Pulmonology, Pleural Disease
Physician
Are you Dr. Chauhan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 26 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
611 South Carlin Springs Rd
511
Arlington, VA 22204
Summary
- Dr. Ashok Chauhan, MD is a pulmonologist in Arlington, Virginia. He is currently licensed to practice medicine in Virginia, District of Columbia, and Maryland. He is affiliated with Inova Alexandria Hospital, Inova Mount Vernon Hospital, and Inova Loudoun Hospital.
Education & Training
University Saskatchewan Royal HospitalPulmonary Disease, 1992 - 1994- Providence HospitalResidency, Internal Medicine, 1989 - 1992
Delhi University College of Medical SciencesClass of 1985
Certifications & Licensure
DC State Medical License 1995 - Present
VA State Medical License 1994 - 2026
MD State Medical License 1991 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 8 citationsChimeric peptide-mediated siRNA transduction to inhibit HIV-1 infection.Shalmali Bivalkar-Mehla, Rajeev Mehla, Ashok Chauhan
Journal of Drug Targeting. 2017-04-21 - 31 citationsNeuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation.Maria Podbielska, Arabinda Das, Amena W. Smith, Ashok Chauhan, Swapan K. Ray
Journal of Neurochemistry. 2016-10-18 - 24 citationsEnigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agentAshok Chauhan
Microbes and Infection. 2015-09-01
Press Mentions
The Gut-Brain Axis: Two Ways Signaling in Parkinson’s DiseaseMarch 2nd, 2021
Preparation and Characterization of Nanocurcumin Based Hybrid Virosomes as a Drug Delivery Vehicle with Enhanced Anticancerous Activity and Reduced ToxicityJanuary 11th, 2021- Preparation and Characterization of Nanocurcumin Based Hybrid Virosomes as a Drug Delivery Vehicle with Enhanced Anticancerous Activity and Reduced ToxicityJanuary 11th, 2021
- Join now to see all
Professional Memberships
- Member
